Showing results (661-670 of 689) with videos related to

Sort By:
Pageof 69
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Blood|March 14, 2019
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemiaIan W Flinn, John G Gribben, Martin J S Dyer, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease TrialsS Walter, O Langford, G A Jimenez-Maggiora, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs)Brian Clarke, Emmanuel Demont, Colin Dingwall, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2007
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assaysC M Britten, C Gouttefangeas, M J P Welters, et al.
Lancet Regional Health. Americas|June 1, 2022
The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology studyKatharine S Walter, Paulo César Pereira Dos Santos, Thais Oliveira Gonçalves, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic characterBrian Clarke, Emmanuel Demont, Colin Dingwall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptorMuna H Abdi, Paul J Beswick, Andy Billinton, et al.
British Journal of Haematology|November 5, 2019
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemiaToby A Eyre, Lindsey E Roeker, Christopher P Fox, et al.
Pageof 69